These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16700816

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine.
    Jokinen MJ, Olkkola KT, Ahonen J, Neuvonen PJ.
    Clin Pharmacol Ther; 2001 Oct; 70(4):344-50. PubMed ID: 11673750
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Rifampicin markedly decreases plasma concentration and hypnotic effect of brotizolam.
    Ujiie Y, Fukasawa T, Yasui-Furukori N, Suzuki A, Tateishi T, Otani K.
    Ther Drug Monit; 2006 Jun; 28(3):299-302. PubMed ID: 16778710
    [Abstract] [Full Text] [Related]

  • 25. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
    Backman JT, Granfors MT, Neuvonen PJ.
    Eur J Clin Pharmacol; 2006 Jun; 62(6):451-61. PubMed ID: 16758262
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 27. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of atenolol in clinically normal cats.
    Quiñones M, Dyer DC, Ware WA, Mehvar R.
    Am J Vet Res; 1996 Jul; 57(7):1050-3. PubMed ID: 8807020
    [Abstract] [Full Text] [Related]

  • 29. Khat chewing and arterial blood pressure. A randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoceptor blockade.
    Hassan NA, Gunaid AA, El-Khally FM, Al-Noami MY, Murray-Lyon IM.
    Saudi Med J; 2005 Apr; 26(4):537-41. PubMed ID: 15900355
    [Abstract] [Full Text] [Related]

  • 30. Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin).
    Clementi WA, Garvey TQ, Clifton GD, McCoy RA, Brandt S, Schwartz S.
    Chirality; 1994 Apr; 6(3):169-74. PubMed ID: 8024947
    [Abstract] [Full Text] [Related]

  • 31. Effect of bifendate on the pharmacokinetics of talinolol in healthy subjects.
    Zeng Y, He FY, He YJ, Dai LL, Fan L, Zhou HH.
    Xenobiotica; 2009 Nov; 39(11):844-9. PubMed ID: 19845435
    [Abstract] [Full Text] [Related]

  • 32. Effect of unilateral nephrectomy on the pharmacokinetics of atenolol in humans.
    Drozdzik M, Domanski L, Wojcicki J, Pudlo A, Machoy P.
    J Clin Pharmacol; 2003 May; 43(5):524-8. PubMed ID: 12751273
    [Abstract] [Full Text] [Related]

  • 33. Steady-state fluctuation and variability of betaxolol and atenolol plasma levels.
    Kunka RL, Wong YY, Andersen RL, Haack DG.
    Ther Drug Monit; 1989 Sep; 11(5):523-7. PubMed ID: 2573178
    [Abstract] [Full Text] [Related]

  • 34. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
    Stoschitzky K, Egginger G, Zernig G, Klein W, Lindner W.
    Chirality; 1993 Sep; 5(1):15-9. PubMed ID: 8383518
    [Abstract] [Full Text] [Related]

  • 35. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN, Falcon RW.
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [Abstract] [Full Text] [Related]

  • 36. [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
    Telatyńska-Smieszek B.
    Ann Acad Med Stetin; 2002 Aug; 48():367-80. PubMed ID: 14601489
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study.
    Zhang W, Deng S, Chen XP, Zhou G, Xie HT, He FY, Cao D, Li YJ, Zhou HH.
    Clin Ther; 2008 Jul; 30(7):1283-9. PubMed ID: 18691987
    [Abstract] [Full Text] [Related]

  • 38. Rifampicin has a profound effect on the pharmacokinetics of oral S-ketamine and less on intravenous S-ketamine.
    Peltoniemi MA, Saari TI, Hagelberg NM, Laine K, Kurkinen KJ, Neuvonen PJ, Olkkola KT.
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):325-32. PubMed ID: 22676424
    [Abstract] [Full Text] [Related]

  • 39. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y, Miura M, Yasui-Furukori N, Ieiri I, Uno T.
    J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
    [Abstract] [Full Text] [Related]

  • 40. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
    Telatyńska B, Wójcicki J, Droździk M, Gawrońska-Szklarz B, Sulzyc-Bielicka V, Sterna R.
    Pol J Pharmacol; 2003 Feb; 55(1):81-9. PubMed ID: 12856830
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.